Abstract
Drug-related problems include medication errors (involving an error in the process of prescribing, dispensing, or administering a drug, whether there are adverse consequences or not) and adverse drug reactions (any response to a drug which is noxious and unintended, and which occurs at doses normally used in humans for prophylaxis, diagnosis or therapy of disease, or for the modification of physiological function). Furthermore, adverse drug events can be defined as an injury — whether or not causally-related to the use of a drug.
Drug-related problems are relatively common in hospitalised patients and can result in patient morbidity and mortality, and increased costs. In order to get an overview of studies on drug-related problems in hospitalised patients, with specific attention to the incidence of drug-related problems and their costs, to the possibilities of prevention and to the effect of these interventions, we performed a literature search.
Incidences of medication errors reported in studies vary widely. The range of reported incidences of adverse drug reactions is even wider. These wide ranges can be largely explained by the different study methods and definitions used.
Problems related to drug therapy may be averted by preventive interventions. Several possibilities for prevention exist, especially for the prevention of medication errors. Prescribing, transcription and interpretation errors can be reduced by using computerised physician order entry. Together with the use of automated dispensing systems and bar-code technology, this will aid in the reduction of both dispensing and administration errors. Education of nursing staff involved in the process of drug distribution is another important measure for preventing medication errors. Finally, the introduction of systems for the early detection of adverse drug reactions may help to reduce problems related to drug therapy. Identifying risk factors that contribute to the development of adverse drug reactions, may aid in the prevention of these reactions.
Similar content being viewed by others
References
Meyboom RHB, Egberts ACG, Edwards R, et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997; 16: 355–65
Phillips DP, Christenfeld N, Glynn LM. Increase in US medication-error deaths between 1983 and 1993. Lancet 1998; 351: 643–4
Bates DW. Drugs and adverse drug reactions: how worried should we be? JAMA 1998; 279: 1216–7
Johnson JA, Bootman JL. Drug-related morbidity and mortality — a cost-of-illness model. Arch Intern Med 1995; 155: 1949–56
Pirmohamed M, Breckenridge AM, Kitteringham NR, et al. Adverse drug reactions. BMJ 1998; 316: 1295–8
Leape LL. Preventing adverse drug events. Am J Health Syst Pharm 1995; 52: 379–82
Anonymus. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm 1995; 52:417–9
Bradbury K, Wang J, Haskins G, et al. Prevention of medication errors. Developing a continuous-quality-improvement approach. Mt Sinai J Med 1993; 60: 379–86
Vitillo J, Lesar TS. Preventing medication prescribing errors. DICP 1991; 25: 1388–94
Dean BS, Allan EL, Barber ND, et al. Comparison of medication errors in an American and a British hospital. Am J Health Syst Pharm 1995; 52: 2543–9
Taxis K, Dean B, Barber N. Hospital drug distribution systems in the UK and Germany - a study of medication errors. Pharm World Sci 1999; 21: 25–31
McNally KM, Sunderland VB. No-blame medication administration error reporting by nursing staff at a teaching hospital in Australia. Int J Pharm Pract 1998; 6: 67–71
Schneider MP, Cotting J, Pannatier A. Evaluation of nurses’ errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci 1998; 20: 178–82
Tissot E, Cornette C, Demoly P, et al. Medication errors at the administration stage in an intensive care unit. Intensive Care Med 1999; 25: 353–9
Shaughnessy AF, D’Amico F. Long-term experience with a program to improve prescription-writing skills. Fam Med 1994; 26: 168–71
Schumock GT, Guenette AJ, Keys TW, et al. Prescribing errors for patients about to be discharged from a university teaching hospital. Am J Hosp Pharm 1994; 51: 2288–90
Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. Arch Intern Med 1997; 157: 1569–76
Bates DW, Boyle DL, Vander Vliet MB, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10: 199–205
Hartwig SC, Denger SD, Schneider PJ. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm 1991; 48: 2611–6
Lacasa C, Cot R, Roure C, et al. Medication errors in a general hospital. Eur Hosp Pharm 1998; 4: 35–40
Schumock GT, Thornton JP, Witte KW. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions. Am J Hosp Pharm 1991; 48: 1974–6
Classen DC, Pestotnik SL, Evans RS, et al. Description of a computerized adverse drug event monitor using a hospital information system. Hosp Pharm 1992; 27(9): 774, 776-9, 783
Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847–51
Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300
Wodtke JM, Generali JA. Use of medical record codes to identify adverse drug reactions. Am J Hosp Pharm 1993; 50: 1915–6
Madsen JJ. Comparison of concurrent and retrospective methods of detecting adverse drug reactions. Am J Hosp Pharm 1993; 50: 2556–7
van Kraaij DJW, Haagsma CJ, Go IH, et al. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth J Med 1994; 44: 166–73
Nazario M, Feliu JF, Rivera GC. Adverse drug reactions: The San Juan Department of Veterans Affairs Medical Center experience. Hosp Pharm 1994; 29: 244–46, 249-50
Chan TYK, Critchley JAJH. Reporting of adverse drug reactions in relation to general medical admissions to a teaching hospital in Hong Kong. Pharmacoepidemiol Drug Saf 1994; 3: 85–9
Bowman L, Carlstedt BC, Black CD. Incidence of adverse drug reactions in adult medical inpatients. Can J Hosp Pharm 1994; 47: 209–16
Pearson TF, Pittman DG, Longley JM, et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51: 2268–72
Vandel P, Bizouard P, Vandel S, et al. Undesirable effects of drugs: epidemiologic study at a psychiatric service of a university hospital [in french]. Therapie 1995; 50: 67–72
Johnstone DM, Kirking DM, Vinson BE. Comparison of adverse drug reactions detected by pharmacy and medical records departments. Am J Health Syst Pharm 1995; 52: 297–301
Sacilotto K, Bagheri H, Lapeyre-Mestre M, et al. Adverse drug effect notifications by nurses and comparison with cases reported by physicians [in French]. Therapie 1995; 50: 455–8
Hall M, McCormack P, Arthurs N, et al. The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol 1995; 40: 173–5
Orsini MJ, Orsini PAF, Thorn DB, et al. An ADR surveillance program: increasing quality, number of incidence reports. Formulary 1995; 30: 454–61
Cosentino M, Leoni O, Rispoli L, et al. A 1-year study of drug prescriptions and adverse drug reactions in psychiatric hospital practice. Pharmacoepidemiol Drug Saf 1996; 5: 377–84
Lin Wu F, Yang C, Shen L, et al. Adverse drug reactions in a medical ward. J Formos Med Assoc 1996; 95: 241–6
Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42: 423–9
Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. JAMA 1997; 277: 301–6
Vargas E, Navarro MI, Laredo L, et al. Effect of drug interactions on the development of adverse drug reactions. Clin Drug Invest 1997; 13: 282–9
Lee A, Bateman N, Edwards C, et al. Reporting of adverse drug reactions by hospital pharmacists: pilot scheme. BMJ 1997; 315: 519
Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301–8
Azaz-Livshits T, Levy M, Sadan B, et al. Computerized surveillance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 1998; 45: 309–14
Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999; 33: 236–40
Van den Bemt PMLA, Egberts ACG, Lenderink AW, et al. Adverse drug events in hospitalized patients: a comparison of doctors, nurses and patients as sources of reports. Eur J Clin Pharmacol 1999; 55: 155–8
Holland EG, Degruy FV. Drug-induced disorders. Am Fam Physician 1997; 56: 1781–8
Seeger JD, Schumock GT, Xiaodong Kong S. Estimating the rate of adverse drug reactions with capture-recapture analysis.Am J Health Syst Pharm 1996; 53: 178–81
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5
Tully MP, Tallis RC. Inappropriate prescribing and adverse drug reactions in patients admitted to an elderly care unit. J Geriatr Drug Ther 1991; 6: 63–74
Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med 1991; 370–6
Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377–84
Leape LL, Lawthers AG, Brennan TA, et al. Preventing medical injury. Qual Rev Bull 1993; 19: 144–9
Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993; 8: 289–94
Cullen DJ, Bates DW, Small SD, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995; 21: 541–8
Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29–34
Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995; 274: 35–43
Cullen DJ, Sweitzer BJ, Bates DW, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997; 25: 1289–97
Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277: 307–11
Vargas E, Simon J, Martin J-C, et al. Effect of adverse drug reactions on length of stay in intensive care units. Clin Drug Invest 1998; 15: 353–60
Schneider PJ, Gift MG, Lee YP, et al. Cost of medication related problems at a university hospital. Am J Health Syst Pharm 1995; 52: 2415–8
Seeger JD, Xiaodong Kong S, Schumock GT. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy 1998; 18: 1284–9
Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277: 312–7
Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm 1994; 29: 319–30
Petersen LA, Brennan TA, O’Neil AC, et al. Does housestaff discontinuity of care increase the risk for preventable adverse effects? Ann Intern Med 1994; 121: 866–72
Leape LL. Error in medicine. JAMA 1994; 272: 1851–7
Lesar TS. Errors in the use of medication dosage equations. Arch Pediatr Adolesc Med 1998; 152: 340–4
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49: 2229–32
Evans RS, Pestotnik SL, Classen DC, et al. Preventing adverse drug events in hospitalized patients. Ann Pharmacother 1994; 28: 523–7
Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events. JAMA 1998; 280: 1317–20
Anderson JG, Jay SJ, Anderson M, et al. Evaluating the potential effectiveness of using computerized information systems to prevent adverse drug events. Proc AMIA Annu Fall Symp 1997: 228–32
Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311–6
Bates DW, Teich JM, Lee J et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999; 6: 313–21
Leape LL, Cullen DJ, Dempsey Clapp M, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267–70
Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing and drug costs in United States hospitals. Pharmacotherapy 1999; 19: 1354–62
West DW, Levine S, Magram G, et al. Pediatric medication order error rates related to the mode of order transmission. Arch Pediatr Adolesc Med 1994; 148: 1322–6
Attilio RM. Caring enough to understand: the road to oncology medication error prevention. Hosp Pharm 1996; 31: 17–26
Robertson WO. Errors in prescribing. Am J Health Syst Pharm 1995; 52: 382–5
Kelly WN. Pharmacy contributions to adverse medication events. Am J Health Syst Pharm 1995; 52: 385–90
Anonymus. Top-priority actions for preventing adverse drug events in hospitals: recommendations of an expert panel. Am J Health Syst Pharm 1996; 53: 747–51
Klein EG, Santora JA, Pascale PM, et al. Medication cart-filling time, accuracy, and cost with an automated dispensing system. Am J Hosp Pharm 1994; 51: 1193–6
Pepper GA. Errors in drug administration by nurses. Am J Health Syst Pharm 1995; 52: 390–5
D’Arcy PF. Adverse drug reactions in hospital and in the community. Adverse Drug React Toxicol Rev 1997; 16: 95–101
Park BK, Pirmohamed M, Kitteringham NR. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992; 34: 377–95
Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991; 39: 1093–9
Atkin PA, Shenfield GM. Medication-related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev 1995; 14: 175–91
Kando JC, Yonkers KA, Cole JO. Gender as a risk factor for adverse events to medications. Drugs 1995; 50: 1–6
Tran C, Knowles SR, Liu BA, et al. Gender differences in adverse drug reactions. J Clin Pharmacol 1998; 38: 1003–9
Bates DW, Miller EB, Cullen DJ et al. Patient risk factors for adverse drug reactions in hospitalized patients. Arch Intern Med 1999; 159: 2553–60
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van den Bemt, P.M., Egberts, T.C., de Jong-van den Berg, L.T. et al. Drug-Related Problems in Hospitalised Patients. Drug-Safety 22, 321–333 (2000). https://doi.org/10.2165/00002018-200022040-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200022040-00005